Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Anti-LAG-3 + Anti-PD-1 Immunotherapy for Cancer
Recruiting1 awardPhase 1 & 2
Dallas, Texas
This trial will test the safety and effectiveness of an experimental medication, BMS-986016, either alone or in combination with nivolumab, in patients with solid tumors that have spread and/or cannot be removed by surgery.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.